iiinova — where your digital self keeps evolving

Randy Dillinger @rdillinger.bsky.social · 31/03/2025

We met some amazing people and organizations today who are championing research and support for breast cancer patients. The full continuum of cancer care was present in strength today for #PinkOutTheStatehouse. So happy @mindidill.bsky.social could join me for this event.

120

Randy Dillinger @rdillinger.bsky.social · 02/03/2025

Strange, but sadly not surprising. Here’s what I’m seeing now.

020

Randy Dillinger @rdillinger.bsky.social · 15/02/2025

Congratulations, Dr. Noah Hahn of Johns Hopkins Kimmel Cancer Center and all co-authors on presentation of the ADAPT-BLADDER (HCRN-GU16-243) Cohort 4 results at #GU25.

020

Randy Dillinger @rdillinger.bsky.social · 13/02/2025

Congratulations, Dr. Rana McKay and Dr. Justine Panian of the UCSD Moores Cancer Center, and all study collaborators, on your Trials in Progress poster highlighting the @hoosiercancer.bsky.social CANOPY study at #GI25. #OncSky

010

Randy Dillinger @rdillinger.bsky.social · 25/01/2025

Well attended #GI25 poster walk led by Vaibhav Sahai, MD, MS, of the University of Michigan Rogel Cancer. Dr Sahai is co-chair of the @bigtencrc.bsky.social GI Clinical Trial Working Group.

071

Randy Dillinger @rdillinger.bsky.social · 24/12/2024

Today I reflect on my father, who would have turned 89 yesterday. He is my exemplar of a life well lived. He was the first of my immediate family to pass from #cancer (in 2002 at 66), followed by my sister (2018 at 58) and mom (2021 at 84). Their memory motivates me daily. #HolidayReflection #OncSky

040

Randy Dillinger @rdillinger.bsky.social · 14/12/2024

Congrats to all #BigTen cancer researchers who presented at #SABCS24. Our team managed to visit some of your posters, but there were so many others at the meeting. Wish we could have visited all! @rutgerscancer.bsky.social

041

Randy Dillinger @rdillinger.bsky.social · 14/12/2024

We are grateful to all who joined the Hoosier Cancer Research Network #breastcancer research meeting at #SABCS24. Great discussion on currently enrolling #clinicaltrials and potential new multi-center IITs.

030

Randy Dillinger @rdillinger.bsky.social · 12/12/2024

Annual gathering of the Big Ten CRC #breastcancer research team at #SABCS24. Great turnout and discussion! @kariwisinskimd.bsky.social

050

Randy Dillinger @rdillinger.bsky.social · 11/12/2024

Congratulations to Rutgers University and George Mason University collaborators on your #SABCS24 poster, validation of HER2 activation response predictive signature (HARPS) as predictive biomarker for HER2+ therapy response in neoadj setting.

020

Randy Dillinger @rdillinger.bsky.social · 11/12/2024

Excellent overview of ePRO use in #mBC, and what’s next, presented by Gabrielle Rocque, MD, of University of Alabama at Birmingham. #SABCS24 @sabcs.bsky.social

020

Randy Dillinger @rdillinger.bsky.social · 11/12/2024

Thank you to our Hoosier Cancer Research Network #myeloid working group members for a fantastic lunch discussion during #ASH24.

010

Randy Dillinger @rdillinger.bsky.social · 11/12/2024

Fantastic lunch meeting with Hoosier Cancer Research Network #lymphoma researchers during #ASH24. Thank you to all who attended and contributed to such a productive discussion.

010

Randy Dillinger @rdillinger.bsky.social · 10/12/2024

Thank you to our members who joined our Big Ten CRC #myeloid and #bmt lunch at #ASH24. What a great meeting!

020

Randy Dillinger @rdillinger.bsky.social · 10/12/2024

Great turnout for our Big Ten Cancer Research Consortium #MultipleMyeloma lunch during #ASH24. Thanks to all who joined us!

040

Randy Dillinger @rdillinger.bsky.social · 10/12/2024

Thank you to this great group of #lymphoma researchers who gathered for lively discussion during our lunch meeting at #ASH24.

110

Randy Dillinger @rdillinger.bsky.social · 29/11/2024

The HCRN SOLARA study evaluates the safety and effectiveness of focused radiation therapy (radiosurgery) together with olaparib, followed by immunotherapy, for patients with brain metastases from triple negative or BRCA-mutated breast cancers. Learn more: hoosiercancer.org/clinical-tri...

000